Humira is now officially approved by Health Canada to treat Crohn's disease
September 2007
Humira is now officially approved by Health Canada to treat Crohn's disease.
Humira (adalimumab) is a biologic therapy...similar to Remicade (infliximab). Both drugs block tumor necrosis factor alpha (TNF-alpha)...to help reduce inflammation.
Humira is already used for rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter Canada includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 200+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive